![]() |
Study shows superior activity for nab-paclitaxel vs paclitxel in early breast cancer
The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based...
More... |
| All times are GMT -7. The time now is 01:21 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021